InsidersTradesSigma
Shanghai Bio-heart Biological Technology Co., Ltd. - B: insider trades · Hong Kong · HKEX
HKEX:shanghai-bio-heart-biological-technology-co-ltd-b-h-shHK·HKEXMcap 399M€Healthcare
Discover the full management transaction log of Shanghai Bio-heart Biological Technology Co., Ltd. - B, a publicly traded company based in Hong Kong. Shares trade on HK HK, under the oversight of HKEX. Operating in the Healthcare sector, Shanghai Bio-heart Biological Technology Co., Ltd. - B has logged 21 insider filings. Market capitalisation: €399.2m. The latest transaction was filed on 15 May 2026 — Purchase. Among the most active insiders: Wang Philip Li. The full history is accessible without an account.
21
Insider Decl.
0
Thresholds
€99,815
21 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2024 · cache
3.80 €
Income statement
Net income−87.9 M€
Balance sheet & cash
Market cap399.2 M€
Total debt8.3 M€
Free Cash Flow−166.7 M€
Last declaration on 15 May 2026
Declarations21 total
Executives●Purchase2HKEX
€4,39210,000 shares@ €0.43920.0011% mcap4.4% of flow
ShareXHKG
HKEX:DA20260515E00041·
Ideal exit: 9 Feb 2027 (T+270)
Executives●Purchase2HKEX
€4,44510,000 shares@ €0.44450.0011% mcap4.5% of flow
ShareXHKG
HKEX:DA20260514E00013·
Ideal exit: 8 Feb 2027 (T+270)
Executives●Purchase2HKEX
€4,47010,000 shares@ €0.4470.0011% mcap4.5% of flow
ShareXHKG
HKEX:DA20260513E00437·
Ideal exit: 7 Feb 2027 (T+270)
Executives●Purchase2HKEX
€4,72010,000 shares@ €0.4720.0012% mcap4.7% of flow
ShareXHKG
HKEX:DA20260512E00006·
Ideal exit: 6 Feb 2027 (T+270)
Executives●Purchase2HKEX
€4,84910,000 shares@ €0.48490.0012% mcap4.9% of flow
ShareXHKG
HKEX:DA20260511E00045·
Ideal exit: 5 Feb 2027 (T+270)
Executives●Purchase2HKEX
€4,76610,000 shares@ €0.47660.0012% mcap4.8% of flow
ShareXHKG
HKEX:DA20260508E00259·
Ideal exit: 2 Feb 2027 (T+270)
Executives●Purchase2HKEX
€4,74410,000 shares@ €0.47440.0012% mcap4.8% of flow
ShareXHKG
HKEX:DA20260507E00026·
Ideal exit: 1 Feb 2027 (T+270)
Executives●Purchase2HKEX
€4,95410,000 shares@ €0.49540.0012% mcap5.0% of flow
ShareXHKG
HKEX:DA20260506E00010·
Ideal exit: 31 Jan 2027 (T+270)
Executives●Purchase3HKEX
€5,07110,000 shares@ €0.50710.0013% mcap5.1% of flow
ShareXHKG
HKEX:DA20260505E00032·
Ideal exit: 25 Jan 2027 (T+270)
Executives●Purchase2HKEX
€4,41210,000 shares@ €0.44120.0011% mcap4.4% of flow
ShareXHKG
HKEX:DA20260430E00035·
Ideal exit: 25 Jan 2027 (T+270)
Executives●Purchase2HKEX
€4,54210,000 shares@ €0.45420.0011% mcap4.6% of flow
ShareXHKG
HKEX:DA20260429E00037·
Ideal exit: 24 Jan 2027 (T+270)
Executives●Purchase2HKEX
€4,42210,000 shares@ €0.44220.0011% mcap4.4% of flow
ShareXHKG
HKEX:DA20260428E00035·
Ideal exit: 23 Jan 2027 (T+270)
Executives●Purchase2HKEX
€4,44110,000 shares@ €0.44410.0011% mcap4.4% of flow
ShareXHKG
HKEX:DA20260427E00036·
Ideal exit: 22 Jan 2027 (T+270)
Executives●Purchase3HKEX
€5,00710,000 shares@ €0.50070.0013% mcap5.0% of flow
ShareXHKG
HKEX:DA20260423E00019·
Ideal exit: 18 Jan 2027 (T+270)
Executives●Purchase3HKEX
€5,32310,000 shares@ €0.53230.0013% mcap5.3% of flow
ShareXHKG
HKEX:DA20260422E00018·
Ideal exit: 17 Jan 2027 (T+270)
Executives●Purchase3HKEX
€5,16010,000 shares@ €0.5160.0013% mcap5.2% of flow
ShareXHKG
HKEX:DA20260421E00033·
Ideal exit: 16 Jan 2027 (T+270)
Executives●Purchase3HKEX
€5,19910,000 shares@ €0.51990.0013% mcap5.2% of flow
ShareXHKG
HKEX:DA20260420E00141·
Ideal exit: 15 Jan 2027 (T+270)
Executives●Purchase2HKEX
€4,89210,000 shares@ €0.48920.0012% mcap4.9% of flow
ShareXHKG
HKEX:DA20260417E00066·
Ideal exit: 12 Jan 2027 (T+270)
Executives●Purchase2HKEX
€4,64010,000 shares@ €0.4640.0012% mcap4.6% of flow
ShareXHKG
HKEX:DA20260416E00577·
Ideal exit: 9 Jan 2027 (T+270)
Executives●Purchase2HKEX
€4,76210,000 shares@ €0.47620.0012% mcap4.8% of flow
ShareXHKG
HKEX:DA20260416E00580·
Ideal exit: 11 Jan 2027 (T+270)
Executives●Purchase2HKEX
€4,60610,000 shares@ €0.46060.0012% mcap4.6% of flow
ShareXHKG
HKEX:DA20260416E00579·
Ideal exit: 10 Jan 2027 (T+270)
21 of 21 declarations